Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Professor John Isaacs

Newcastle AuthorsTitleYearFull text
Professor John Isaacs
EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-192021
Professor John Isaacs
Immunogenicity of biologic agents in rheumatology2021
Dr Dag Aarsland
Professor John O'Brien
Dr Clive Ballard
Professor John Isaacs
Professor Alan Thomas
et al.		Mild cognitive impairment: the Manchester consensus2021
Professor John Isaacs
Dr Arthur Pratt
Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial2021
Professor John Isaacs
Transcriptome-wide study of TNF-inhibitor therapy in rheumatoid arthritis reveals early signature of successful treatment2021
Professor John Isaacs
Characterization of Creatine Kinase Levels in Tofacitinib-Treated Patients with Ulcerative Colitis: Results from Clinical Trials2020
Professor John Isaacs
Correction to: Characterization of Creatine Kinase Levels in Tofacitinib‑Treated Patients with Ulcerative Colitis: Results from Clinical Trials (Digestive Diseases and Sciences, (2020), 10.1007/s10620-020-06560-4)2020
Professor John Isaacs
Professor Iain McInnes
EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-22020
Dr Jessica Tarn
Dr Dennis Lendrem
Professor John Isaacs
In search of pathobiological endotypes: a systems approach to early rheumatoid arthritis2020
Dr Dennis Lendrem
Professor John Isaacs
Influenza vaccination and interruption of methotrexate in adult patients in the COVID-19 era: an ongoing dilemma2020
1234567891011121314151617181920...